STEMI ECG
STEMI causes
atherosclerosis, vasospasm, vasculitis, dissection, genetics
STEMI hx
Physical exam findings for STEMI
• Normal
• S4 Gallop – atrial beating forcefully against less compliant, stiffened ventricle
• BP variable
• Sympathetic hyperactivity (increased HR, increased BP) seen in anterior MI
• Parasympathetic hyperactivity (bradycardia, decreased BP) in inferior MI
o GI manifestations
• Heart failure – S3, crackles, increased JVD, new murmur
Early Acute phase for MI
Chronic phase for MI
Zones of Infraction
o Infarction – dead tissue, lacks depolarization
• Q waves
o Injury – deficient blood supply, inability to fully polarize
• ST Segment shifts
o Ischemia – deficient blood supply, impaired repolarization
• T wave changes
Posterior wall infarctions
reciprocal changes in anterior leads
o V1 and V2
• Prominent R wave (reciprocal of posterior Q wave)
• Upright T waves (reciprocal of inverted T wave)
• ST depression (reciprocal of ST elevation)
Labs in MI
o Increased WBC 12,000-15,000 (hours to 2-4 days)
o Increased CRP
o BNP – increased in ventricular wall stress and fluid overload
Troponin I
non-MI cardiac causes for elevated troponin level
Pulmonary causes for elevated troponin
• PE, pulmonary HTN, respiratory failure
Neurologic causes for elevated troponin
stroke, intracranial hemorrhage
Other causes of elevated troponin
* Renal failure
Standard of care STEMI
o 12 lead ECG with continuous cardiac monitoring
o IV lines inserted
o Cardiac enzymes (cTnI), CBC, CMP, PT, PTT
Primary percutaneous coronary intervention (PCI)
with angioplasty and stenting
• Within 12 hours
• Lower mortality rate and intracerebral hemorrhage
Cath lab
within 90 minutes
• Transport to other hospital if needed within 120 min
Fibrinolysis (clot busters)
Reperfusion therapy
* Failure of ST elevation to resolve by >50-70% within 1-2 hours, suggests failure of fibrinolysis
Initial medical management of STEMI
o ASA (162-325 mg) PO – given on presentation – unless contraindicated • Helps prevent platelet aggregation
o IV Heparin or Enoxaparin
• Adenosine diphosphate receptor (p2Y12) inhibitor
• Antiplatelet agent
• Use for 1 year after PCI for STEMI with stenting to prevent stent stenosis
Treatment of STEMI
o Nitroglycerin – relieve vasoconstriction, relieve pain, reduce pre and afterload
o Morphine – persistent pain
o Beta blocker – esp if increased BP or increased HR
• Don’t use in decompensated HF, decreased HR or BP, MCO2
o Oxygen
o Stool softener (avoid valsalva)
o ACEI – helpful if low EF, increased BP – prevent remodeling
o Coronary ICU – AHA diet
Complications of MI - pericarditis
Complications of MI - Arrhythmias
o Ventricular rhythm disturbance • Occur early • VF in 1st 4 hours – treat via elective cardioversion • VT • VT (polymorphic VT) • VF
o Accelerated Idioventricular Rhythm
• Slow VT (60-100/min)
• After fibrinolytic therapy
• Benign, still irritable
o Atrial fibrillation - First 24 hours (5-10%)
o Sinus Bradycardia
• Included parasympathetic tone
• Associated with inferior MI (up to 40%)
o Second degree AV Block (Wenckebach)
• Associated with inferior wall MI
Complications of MI - HF
leading cause of death after AMI
• LV dysfunction – S3, S4 crackles
• RV infarction – 10-30% of inferior STEMI
• Decreased BP, clear lungs, increased JVP
• Kussmaul sign (distention of jugular vein on inspiration)
• Treat with IV fluids
• Cardiogenic shock – decreased BP, decreased CI (>1.8 L/min/m2)
• Increased Pulmonary capillary wedge pressure (PCWP) >18 mmHg
• Mortality 70-80%